Home/Granite Bio/Patrick Loustau
PL

Patrick Loustau

President and Chief Executive Officer

Granite Bio

Granite Bio Pipeline

DrugIndicationPhase
GRT-001Inflammatory Bowel Disease (Autoimmunity/Inflammation)Phase 1b
GRT-002Itch, Allergy, Inflammation (Type II Inflammation)Preclinical